PT673937E - Derivados biciclicos heterociclicos de sulfonamida e de ester sulfonico - Google Patents
Derivados biciclicos heterociclicos de sulfonamida e de ester sulfonicoInfo
- Publication number
- PT673937E PT673937E PT94926372T PT94926372T PT673937E PT 673937 E PT673937 E PT 673937E PT 94926372 T PT94926372 T PT 94926372T PT 94926372 T PT94926372 T PT 94926372T PT 673937 E PT673937 E PT 673937E
- Authority
- PT
- Portugal
- Prior art keywords
- ring
- nitrogen
- optionally substituted
- sulfonamide
- sulfononic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP24861493 | 1993-09-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT673937E true PT673937E (pt) | 2004-04-30 |
Family
ID=17180741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT94926372T PT673937E (pt) | 1993-09-10 | 1994-09-08 | Derivados biciclicos heterociclicos de sulfonamida e de ester sulfonico |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5767283A (pt) |
| EP (1) | EP0673937B1 (pt) |
| KR (2) | KR0174752B1 (pt) |
| CN (2) | CN1221533C (pt) |
| AT (1) | ATE255106T1 (pt) |
| AU (2) | AU683492B2 (pt) |
| CA (1) | CA2146961C (pt) |
| DE (1) | DE69433353T2 (pt) |
| DK (1) | DK0673937T3 (pt) |
| ES (1) | ES2206469T3 (pt) |
| HU (1) | HU224069B1 (pt) |
| NO (1) | NO303778B1 (pt) |
| NZ (1) | NZ273073A (pt) |
| PT (1) | PT673937E (pt) |
| RU (2) | RU2128648C1 (pt) |
| WO (1) | WO1995007276A1 (pt) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69413183T2 (de) * | 1993-06-25 | 1999-02-11 | Kumiai Chemical Industry Co | Indazolsulfonylharnstoff-derivat, verwendung und zwischenprodukte zur herstellung |
| WO1996034866A1 (en) * | 1995-05-01 | 1996-11-07 | Fujisawa Pharmaceutical Co., Ltd. | Imidazo 1,2-a pyridine and imidazo 1,2-a pyridezine derivatives and their use as bone resorption inhibitors |
| WO1997030706A1 (fr) * | 1996-02-26 | 1997-08-28 | Eisai Co., Ltd. | Compositions contenant un agent antitumoral |
| JP2000247949A (ja) * | 1999-02-26 | 2000-09-12 | Eisai Co Ltd | スルホンアミド含有インドール化合物 |
| JP4516942B2 (ja) * | 1999-02-26 | 2010-08-04 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | スルホンアミド含有インドール化合物 |
| US6653309B1 (en) | 1999-04-26 | 2003-11-25 | Vertex Pharmaceuticals Incorporated | Inhibitors of IMPDH enzyme technical field of the invention |
| US6521658B1 (en) | 1999-05-28 | 2003-02-18 | Abbott Laboratories | Cell proliferation inhibitors |
| EP1258252B1 (en) * | 2000-02-03 | 2010-04-21 | Eisai R&D Management Co., Ltd. | Integrin expression inhibitors |
| KR100767002B1 (ko) * | 2000-02-03 | 2007-10-15 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 인테그린 발현 저해제 |
| TWI283575B (en) * | 2000-10-31 | 2007-07-11 | Eisai Co Ltd | Medicinal compositions for concomitant use as anticancer agent |
| WO2002042493A1 (fr) * | 2000-11-24 | 2002-05-30 | Eisai C0. Ltd. | Procede d'essai de la sensibilite aux agents anticancereux de cellules tumorales |
| ES2317368T3 (es) * | 2001-02-21 | 2009-04-16 | EISAI R&D MANAGEMENT CO., LTD. | Metodo para evaluar el efecto de un inhibidor de la angiogenesis a traves de la inhibicion de la expresion de la integrina. |
| US7186745B2 (en) | 2001-03-06 | 2007-03-06 | Astrazeneca Ab | Indolone derivatives having vascular damaging activity |
| EP1430894A4 (en) * | 2001-09-05 | 2007-12-12 | Eisai R&D Man Co Ltd | LYMPHOCYTE ACTIVATION INHIBITOR AND REMEDY FOR AUTOIMMUNE DISEASE |
| ES2293068T3 (es) | 2002-09-19 | 2008-03-16 | Schering Corporation | Imidazopiridinas como inhibidores de quinasas dependientes de ciclina. |
| WO2006030941A1 (ja) | 2004-09-13 | 2006-03-23 | Eisai R & D Management Co., Ltd. | スルホンアミド含有化合物の血管新生阻害物質との併用 |
| US8772269B2 (en) | 2004-09-13 | 2014-07-08 | Eisai R&D Management Co., Ltd. | Use of sulfonamide-including compounds in combination with angiogenesis inhibitors |
| WO2006054456A1 (ja) * | 2004-11-17 | 2006-05-26 | Eisai R & D Management Co., Ltd. | 二環式へテロ環含有スルホンアミド化合物の結晶 |
| CN101163468A (zh) * | 2005-02-28 | 2008-04-16 | 卫材R&D管理有限公司 | 磺酰胺化合物的新联合用途 |
| EP2308839B1 (en) * | 2005-04-20 | 2017-03-01 | Takeda Pharmaceutical Company Limited | Fused heterocyclic compounds |
| PT1888550E (pt) * | 2005-05-12 | 2014-09-03 | Abbvie Bahamas Ltd | Promotores de apoptose |
| EP2015070A4 (en) | 2006-04-20 | 2010-04-21 | Eisai R&D Man Co Ltd | NEW MARKER AGAINST SENSITIVITY TO A SULFONAMIDE COMPOUND |
| KR101444486B1 (ko) * | 2006-10-19 | 2014-09-24 | 다케다 야쿠힌 고교 가부시키가이샤 | 인돌 화합물 |
| EP2134684B1 (en) * | 2007-04-16 | 2017-08-02 | AbbVie Inc. | 7-substituted indole as mcl-1 inhibitors |
| JP5323834B2 (ja) * | 2007-08-17 | 2013-10-23 | エルジー・ライフ・サイエンシーズ・リミテッド | 細胞壊死阻害剤としてのインドール化合物 |
| JP5188583B2 (ja) | 2008-01-04 | 2013-04-24 | エルジー・ライフ・サイエンシーズ・リミテッド | 細胞、組織及び臓器保存効果を有するインドール及びインダゾール誘導体 |
| EP2229929B1 (en) | 2009-03-18 | 2017-06-14 | DENTSPLY DETREY GmbH | Temporary root canal sealer dispersion |
| TWI410408B (zh) * | 2010-03-16 | 2013-10-01 | Purzer Pharmaceutical Co Ltd | 苯磺醯胺衍生物及其醫藥組合物 |
| CN102199148A (zh) * | 2010-03-25 | 2011-09-28 | 瑞安大药厂股份有限公司 | 苯磺酰胺衍生物及其医药组合物 |
| WO2012056319A1 (en) * | 2010-10-27 | 2012-05-03 | Dynamix Pharmaceuticals Ltd. | Sulfonamides for the modulation of pkm2 |
| CN102875549B (zh) * | 2012-09-14 | 2015-11-04 | 浙江大学 | 7-芳（甲）胺基-5-胺基-6-氮杂吲哚衍生物及制备与用途 |
| CN105658625B (zh) | 2013-08-22 | 2019-05-03 | 株式会社Lg化学 | 作为细胞坏死阻碍剂的吲哚酰胺化合物 |
| EP3037418B1 (en) | 2013-08-22 | 2019-10-02 | LG Chem, Ltd. | Indole compound as inhibitor of necrosis |
| WO2020256430A1 (ko) | 2019-06-19 | 2020-12-24 | 주식회사 엘지화학 | 인돌 또는 인다졸 화합물의 제조방법 |
| KR102389717B1 (ko) | 2019-06-19 | 2022-04-25 | 주식회사 엘지화학 | 인돌 또는 인다졸 화합물의 제조방법 |
| KR102397752B1 (ko) | 2019-06-19 | 2022-05-16 | 주식회사 엘지화학 | 인돌 또는 인다졸 화합물의 제조방법 |
| EP3971184B1 (en) | 2019-06-19 | 2024-04-03 | LG Chem, Ltd. | Method for preparing indole or indazole compound |
| WO2023064669A2 (en) * | 2021-09-21 | 2023-04-20 | The Trustees Of Princeton University | Inhibitors of the mtdh-snd1 protein complex for cancer therapy |
| MA54773B1 (fr) * | 2021-10-29 | 2023-10-31 | Univ Euro Mediterraneenne De Fes Uemf | Nouvelles familles de composés à base de sulfonamides pour le traitement du cancer du sein triple négatif |
| WO2024039689A1 (en) * | 2022-08-15 | 2024-02-22 | Recursion Pharmaceuticals, Inc. | Heterocycle rbm39 modulators |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS539256A (en) * | 1976-07-14 | 1978-01-27 | Hitachi Kiden Kogyo Kk | Two hook type club |
| DE3686688T2 (de) * | 1985-06-24 | 1993-03-18 | Merck & Co Inc | Verwendung von sulfanilamido quinoxalinen zur behandlung von neoplastischen krankheiten. |
| JP2790926B2 (ja) * | 1990-08-20 | 1998-08-27 | エーザイ株式会社 | スルホンアミド誘導体 |
| LU87814A1 (fr) * | 1990-09-27 | 1992-05-25 | Oreal | Composition cosmetique comportant une dispersion de vesicules lipidiques ainsi que des pigments melaniques,et son utilisation |
-
1994
- 1994-09-08 AU AU76237/94A patent/AU683492B2/en not_active Ceased
- 1994-09-08 DK DK94926372T patent/DK0673937T3/da active
- 1994-09-08 CN CNB011194561A patent/CN1221533C/zh not_active Expired - Fee Related
- 1994-09-08 DE DE69433353T patent/DE69433353T2/de not_active Expired - Lifetime
- 1994-09-08 ES ES94926372T patent/ES2206469T3/es not_active Expired - Lifetime
- 1994-09-08 WO PCT/JP1994/001487 patent/WO1995007276A1/ja active IP Right Grant
- 1994-09-08 KR KR1019950701862A patent/KR0174752B1/ko not_active IP Right Cessation
- 1994-09-08 PT PT94926372T patent/PT673937E/pt unknown
- 1994-09-08 RU RU95112848A patent/RU2128648C1/ru not_active IP Right Cessation
- 1994-09-08 CA CA002146961A patent/CA2146961C/en not_active Expired - Fee Related
- 1994-09-08 HU HU9501363A patent/HU224069B1/hu not_active IP Right Cessation
- 1994-09-08 NZ NZ273073A patent/NZ273073A/en not_active IP Right Cessation
- 1994-09-08 EP EP94926372A patent/EP0673937B1/en not_active Expired - Lifetime
- 1994-09-08 CN CN94190672A patent/CN1079097C/zh not_active Expired - Fee Related
- 1994-09-08 AT AT94926372T patent/ATE255106T1/de active
- 1994-09-08 RU RU96119782A patent/RU2121997C1/ru not_active IP Right Cessation
-
1995
- 1995-05-09 NO NO19951813A patent/NO303778B1/no not_active IP Right Cessation
-
1997
- 1997-01-17 US US08/785,610 patent/US5767283A/en not_active Expired - Lifetime
- 1997-04-09 AU AU17785/97A patent/AU711438B2/en not_active Ceased
-
1998
- 1998-09-07 KR KR1019980707044A patent/KR100188846B1/ko not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU7623794A (en) | 1995-03-27 |
| NO303778B1 (no) | 1998-08-31 |
| ATE255106T1 (de) | 2003-12-15 |
| CN1491941A (zh) | 2004-04-28 |
| KR950704304A (ko) | 1995-11-17 |
| EP0673937A1 (en) | 1995-09-27 |
| CA2146961A1 (en) | 1995-03-16 |
| DK0673937T3 (da) | 2004-03-22 |
| RU2121997C1 (ru) | 1998-11-20 |
| DE69433353D1 (de) | 2004-01-08 |
| EP0673937A4 (en) | 1996-01-17 |
| AU683492B2 (en) | 1997-11-13 |
| CA2146961C (en) | 2006-11-07 |
| KR0174752B1 (ko) | 1999-02-01 |
| US5767283A (en) | 1998-06-16 |
| WO1995007276A1 (fr) | 1995-03-16 |
| RU95112848A (ru) | 1997-03-20 |
| CN1079097C (zh) | 2002-02-13 |
| CN1221533C (zh) | 2005-10-05 |
| ES2206469T3 (es) | 2004-05-16 |
| NO951813D0 (no) | 1995-05-09 |
| NO951813L (no) | 1995-05-09 |
| NZ273073A (en) | 1996-09-25 |
| HUT71551A (en) | 1995-12-28 |
| HU9501363D0 (en) | 1995-06-28 |
| RU2128648C1 (ru) | 1999-04-10 |
| EP0673937B1 (en) | 2003-11-26 |
| AU711438B2 (en) | 1999-10-14 |
| AU1778597A (en) | 1997-08-14 |
| HU224069B1 (hu) | 2005-05-30 |
| CN1114506A (zh) | 1996-01-03 |
| DE69433353T2 (de) | 2004-09-09 |
| KR100188846B1 (en) | 1999-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT673937E (pt) | Derivados biciclicos heterociclicos de sulfonamida e de ester sulfonico | |
| AU6876894A (en) | New compositions of matter | |
| ES2051772T3 (es) | 2-sustituido-e-fusionado-(1,2,4)-triazol(1,5-c)pirimidinas, composiciones farmaceuticas y sus usos. | |
| AU3015289A (en) | 2'-deoxy-5-fluorouridine derivatives | |
| AU4216993A (en) | Novel arylglycinamide derivatives and preparative processes therefor | |
| FI951416A0 (fi) | Trisykliset heterosykliset sulfonamidi- ja sulfoniesterijohdannaiset | |
| PL309874A1 (en) | Novel derivatives of pyrrolocarbasol, method of obtaining them and pharmaceutical composition containing such derivatives | |
| DK0459505T3 (da) | Imidazonaphthyridinderivater | |
| AU2124992A (en) | Pharmaceutically useful indole derivatives | |
| ATE148128T1 (de) | Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung | |
| EP0878196A4 (en) | INHIBITORS OF KAINIC ACID NEUROTOXICITY AND PYRIDOTHIAZINE DERIVATIVES | |
| ATE190308T1 (de) | Epoxycyclohexendionderivat | |
| DK0601191T3 (da) | Hidtil ukendt tetracyklisk forbindelse | |
| AU3255989A (en) | Heterotetracyclic lactam derivatives | |
| HUT61967A (en) | Process for producing new alkyl aminoalkyl amine- and -ether derivatives and pharmaceutical compositions comprising such compounds | |
| AU8591991A (en) | Piperazine derivatives | |
| NO920619L (no) | Oxazinobenzazolforbindelser | |
| DK480389A (da) | Antitumor-aktivt derivat af sf2587, fremgangsmaade til det fremstilling og anticancermiddel indeholdende stoffet | |
| ATE140919T1 (de) | Indolderivate | |
| AU2001225466A1 (en) | Pyrimidine derivatives having antitumor effect |